Genscript Biotech Stock Price on April 1, 2024
GNNSF Stock | USD 1.25 0.01 0.79% |
If you're considering investing in Genscript Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Genscript Biotech stands at 1.25, as last reported on the 16th of December 2024, with the highest price reaching 1.25 and the lowest price hitting 1.25 during the day. Genscript Biotech holds Efficiency (Sharpe) Ratio of -0.0797, which attests that the entity had a -0.0797% return per unit of risk over the last 3 months. Genscript Biotech exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genscript Biotech's Risk Adjusted Performance of (0.05), standard deviation of 2.03, and Market Risk Adjusted Performance of (0.64) to validate the risk estimate we provide.
Genscript Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Genscript |
Sharpe Ratio = -0.0797
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | GNNSF |
Estimated Market Risk
2.05 actual daily | 18 82% of assets are more volatile |
Expected Return
-0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genscript Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genscript Biotech by adding Genscript Biotech to a well-diversified portfolio.
Related Headline
Lineage Cell Headline on 1st of April 2024
Should You Buy Lineage Cell Therapeutics Inc Stock on Monday... by news.google.com
Should You Buy Lineage Cell Therapeutics Inc Stock on Monday InvestorsObserver
Genscript Biotech Valuation on April 1, 2024
It is possible to determine the worth of Genscript Biotech on a given historical date. On April 1, 2024 Genscript was worth 2.0 at the beginning of the trading date compared to the closed value of 2.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genscript Biotech pink sheet. Still, in general, we apply an absolute valuation method to find Genscript Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genscript Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genscript Biotech's related companies.
Open | High | Low | Close | Volume | |
2.00 | 2.00 | 2.00 | 2.00 | 1.00 | |
04/01/2024 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
Backtest Genscript Biotech | | | Genscript Biotech History | | | Genscript Biotech Valuation | Previous | Next |
Genscript Biotech Trading Date Momentum on April 1, 2024
On April 02 2024 Genscript Biotech was traded for 2.00 at the closing time. The highest daily price throughout the period was 2.00 and the lowest price was 2.00 . There was no trading activity during the period 1.0. Lack of trading volume on 04/02/2024 did not cause price change. The overall trading delta to current closing price is 0.00% . |
Genscript Biotech Fundamentals Correlations and Trends
By evaluating Genscript Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genscript Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genscript financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genscript Biotech Pink Sheet history
Genscript Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genscript is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genscript Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genscript Biotech stock prices may prove useful in developing a viable investing in Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the Peoples Republic of China, Japan, the other Asia Pacific regions, and internationally. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the Peoples Republic of China. Genscript Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5573 people.
Genscript Biotech Pink Sheet Technical Analysis
Genscript Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Genscript Biotech Period Price Range
Low | December 16, 2024
| High |
0.00 | 0.00 |
Genscript Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genscript Biotech December 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Genscript Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genscript Biotech shares will generate the highest return on investment. By undertsting and applying Genscript Biotech pink sheet market strength indicators, traders can identify Genscript Biotech entry and exit signals to maximize returns
Genscript Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genscript Biotech's price direction in advance. Along with the technical and fundamental analysis of Genscript Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genscript to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.19) | |||
Total Risk Alpha | (0.42) | |||
Treynor Ratio | (0.65) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |